Literature DB >> 3795356

Ureteral urine transport: changes in bolus volume, peristaltic frequency, intraluminal pressure and volume of flow resulting from autonomic drugs.

T Morita, I Wada, H Saeki, S Tsuchida, R M Weiss.   

Abstract

An experimental model which permits independent changes in ureteral peristalic frequency and bolus volume was employed to explore the effects of autonomic agonists on ureteral bolus volume, peristaltic frequency, intraluminal pressure and flow volume in the dog. Norepinephrine caused an increase in ureteral peristaltic frequency, an elevation in intraureteral baseline and contractile pressure and a decrease in bolus volume, with a resultant decrease in the rate of fluid transport. Isoproterenol caused a decrease in ureteral peristaltic frequency, and a fall in intraureteral baseline and contractile pressure, or it completely abolished peristalsis and bolus formation. These changes were accompanied by an increase in the rate of fluid transport. Acetylcholine caused an increase in ureteral peristaltic frequency, an elevation of intraureteral baseline pressure but no change in contractile pressure, and a small decrease in bolus volume with a resultant small decrease in the rate of fluid transport. These data suggest that the autonomic nervous system may affect urine transport through the ureter by not only regulating peristaltic frequency but also by influencing bolus volume.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3795356     DOI: 10.1016/s0022-5347(17)43904-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  22 in total

Review 1.  Pharmacotherapy of urolithiasis: evidence from clinical trials.

Authors:  Orson W Moe; Margaret S Pearle; Khashayar Sakhaee
Journal:  Kidney Int       Date:  2010-10-06       Impact factor: 10.612

2.  Evaluation of the efficiency of tamsulosin and Rowatinex in patients with distal ureteral stones: a prospective, randomized, controlled study.

Authors:  Mustafa Aldemir; Yusuf Emre Uçgül; Onder Kayıgil
Journal:  Int Urol Nephrol       Date:  2010-06-10       Impact factor: 2.370

3.  Adjunctive therapy to promote stone passage.

Authors:  Geoffrey R Nuss; Judson D Rackley; Dean G Assimos
Journal:  Rev Urol       Date:  2005

Review 4.  Pharmacological effect on pyeloureteric dynamics with a clinical perspective: a review of the literature.

Authors:  Helene U Jung; Poul C Frimodt-Møller; Palle J Osther; Jens Mortensen
Journal:  Urol Res       Date:  2006-12

Review 5.  Medical expulsive therapy for distal ureteral stones.

Authors:  Vassilios Tzortzis; Charalampos Mamoulakis; Jorge Rioja; Stavros Gravas; Martin C Michel; Jean J M C H de la Rosette
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 6.  Kidney stones: an update on current pharmacological management and future directions.

Authors:  Hongshi Xu; Anna L Zisman; Fredric L Coe; Elaine M Worcester
Journal:  Expert Opin Pharmacother       Date:  2013-03       Impact factor: 3.889

7.  The use of alpha-blockers for the treatment of nephrolithiasis.

Authors:  Michael Lipkin; Ojas Shah
Journal:  Rev Urol       Date:  2006

8.  Different muscarinic receptor subtypes mediating the phasic activity and basal tone of pig isolated intravesical ureter.

Authors:  M Hernández; U Símonsen; D Prieto; L Rivera; P García; E Ordaz; A García-Sacristán
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

9.  Comparative evaluation of efficacy of use of naftopidil and/or celecoxib for medical treatment of distal ureteral stones.

Authors:  Jian Lin Lv; Qing Lai Tang
Journal:  Urolithiasis       Date:  2014-08-20       Impact factor: 3.436

10.  Naftopidil and tolterodine in the medical expulsive therapy for intramural ureteral stones: a prospective randomized study.

Authors:  Jian Lin Lu; Qing Lai Tang; Fa De Liu; Ju Hong Hui
Journal:  Urol Res       Date:  2012-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.